Imperial College London

ProfessorJulianGriffin

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Chair in Biological Chemistry
 
 
 
//

Contact

 

+44 (0)20 7594 3220julian.griffin

 
 
//

Location

 

Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Summary

Professor Griffin obtained his DPhil from the University of Oxford, studying brain biochemistry using 13C NMR spectroscopy in the lab of Sir. Prof. George Radda. He worked as a Harvard Medical School/Massachusetts General Hospital Fellow in Radiology, applying 13C NMR to cardiac metabolism and then as a post-doctoral researcher in the lab of Prof. Jeremy Nicholson at Imperial College London developing metabonomic tools for environmental toxicology. He took up a Royal Society University Research Fellowship at Imperial College and then moved to the Department of Biochemistry, University of Cambridge as a group leader. He was a group leader at MRC Human Nutrition Research and Professor of Metabolism and Nutrition at the University of Cambridge. In 2019 he moved to Imperial College to take up the Chair of Biological Chemistry and head up the Section of Biomolecular Medicine in the Department of Metabolism, Digestion and Reproduction.

His group’s research is focused on understanding how diet interacts with the relative risk of developing metabolic diseases, and, in particular, the use of metabolomics and lipidomics to understand the underlying mechanisms of disease. The group makes use of cell culture, animal studies, human intervention trials and human cohort studies to explore these mechanisms. He is the President of the Metabolomics Society, director of the Metabolic Profiling Forum and a recipient of an Agilent Thought Leader Award in lipidomics.

Professor Griffin’s research is funded by the MRC, EU 2020, the Wellcome Trust, the BBSRC, Alzheimer’s Research UK, the Alzheimer’s Society and NIHR.

Publications

Journals

Vilca-Melendez S, Uthaug M, Griffin J, 2021, 1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?, Frontiers in Psychiatry-psychopharmacology

Jarvis LB, Rainbow DB, Coppard V, et al., 2021, Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73., Commun Biol, Vol:4

Lana-Elola E, Cater H, Watson-Scales S, et al., 2021, Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes., Dis Model Mech, Vol:14

Knatko E, Castro C, Higgins M, et al., 2021, Nrf2 activation does not affect adenoma development in a mouse model of colorectal cancer, Communications Biology, Vol:4

Harshfield EL, Fauman EB, Stacey D, et al., 2021, Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci., Bmc Med, Vol:19

More Publications